For a long time, depression was explained through a simple formula — a shortage of serotonin or dopamine, the so-called “happy” brain chemicals. But anyone who has lived with depression knows it rarely follows a simple rule.

You can take the right medicine, keep every appointment, and still wake up each day feeling heavy, unmotivated, and detached. This gap between what treatment promises and how recovery actually feels has pushed researchers to look elsewhere — beyond chemistry, toward the body’s immune system.

A growing body of work now suggests that inflammation inside the brain, known as neuroinflammation, may quietly shape our mood and energy in ways we’re only beginning to grasp.

What Happens When the Brain’s Immune System Misfires

The brain has its own built-in defence crew. These are cells called microglia, whose job is to keep the place clean — clearing damaged cells, responding to infections, and repairing small injuries.

When they turn on for a short while, they protect the brain. But if they stay active too long, the same reaction that once helped begins to harm.

Imagine a repair team that never stops digging up roads — eventually, they break the ones that were perfectly fine. Something similar happens when microglia stay inflamed.

They start disturbing the brain’s communication lines, dulling circuits that control focus, motivation, and emotional steadiness. Over time, this constant internal irritation can leave a person mentally exhausted or emotionally flat, even when nothing obvious in life has changed.

How Inflammation Shapes Mood

Over the last ten years, scientists have noticed a pattern: people with depression often show higher levels of inflammatory markers such as cytokines. These molecules usually help the body heal.

But when their levels rise too high or stay elevated, they disrupt how nerve cells talk to each other. Inflammation lowers serotonin, interferes with smooth signalling, and limits the brain’s ability to form new connections — what doctors call neuroplasticity.

In everyday terms, depression may not be only a chemical dip. It could be the body’s immune alarm staying switched on too long, quietly clouding both thought and emotion.

Why Some Are More Vulnerable Than Others

Two people can go through the same stress, yet one recovers quickly while the other slips into depression. Part of that difference lies in genetics — how sensitive one’s immune system is — and part in the environment.

Chronic stress, infections, lack of sleep, poor diet, or even difficult childhood experiences can all keep inflammation simmering. In turn, depression itself can raise inflammation, creating a loop that feeds on itself.

This explains why there can never be a one-size-fits-all approach to mental health. Each person’s biology, stress response, and life story shape how their brain reacts.

Changing the Way We Treat Depression

Antidepressants continue to play an important role, especially when depression is moderate or severe. Yet in some people, inflammation seems to be part of the story, and medicines that act only on brain chemicals might not be enough.

Research is now exploring whether easing inflammation—through selected drugs or even through steady lifestyle habits—can work alongside standard therapy to help people feel better for longer.

Advanced neuro-modulation treatment using transcranial magnetic stimulation is one of the latest options now available to help patients, especially when inflammation or standard therapies alone aren’t enough.

Exercise, balanced nutrition rich in omega-3 fats and colourful vegetables, adequate sleep, and stress-reduction methods like meditation or yoga can all help dial down inflammation. These aren’t quick fixes, but they give the brain a better environment to heal and adapt.

A Look Ahead

The understanding that inflammation can influence mood is reshaping how psychiatry looks at mental illness. In the years ahead, treatment may focus more on easing specific inflammatory pathways or strengthening the brain’s natural defences against chronic inflammation.

Many clinicians are already leaning toward more individualised care—using genetic clues, immune patterns, and lifestyle factors to guide how treatment is planned.

When both the chemical and immune sides of depression are addressed, people often describe not just relief from sadness but a clearer sense of energy and control — a steadier ground beneath their feet.

In Closing

Understanding that inflammation can influence mood shifts the way we see mental illness. Depression isn’t only “in the mind”; it’s shaped by the immune system, the environment, and the body’s rhythms.

Recognising this brings compassion into care — it tells patients that what they feel has a physical basis, and that recovery isn’t a matter of willpower alone.

With the right blend of therapy, lifestyle balance, and medical guidance, healing becomes something tangible — not just hope, but a process the body and mind can walk through together.

Disclaimer: The views expressed in this article are of the author and not of Health Dialogues. The Editorial/Content team of Health Dialogues has not contributed to the writing/editing/packaging of this article.

Dr Umesh Tukaram
Dr Umesh Tukaram

Dr Umesh Tukaram (MBBS, MD (General Medicine), DM (Neurology)) is the Clinical Director & Senior Consultant Neurologist at CARE Hospitals, Banjara Hills, Hyderabad with 30 years of experience in neurological care and advanced medical treatments. He specialises in Neuromuscular disease, Epilepsy, Movement disorder, and more. Dr Tukaram completed his MBBS from Dr. B.R. Ambedkar Medical College, Bengaluru, Karnataka. He then pursued his MD in General Medicine from M R Medical College, Gulbarga, Karnataka, followed by a DM in Neurology from T.N. Medical College, Mumbai, Maharashtra. Dr Tukaram was awarded the first rank in the DM Neurology Residency Programme from Bombay University, Mumbai. He underwent specialized epilepsy training at the Epilepsy San Servolo University, Venice, Italy, in 2006. Additionally, he has attended numerous world congresses on neurology, epilepsy, and controversies in neurology.